Indications for the Test
- Initial diagnosis of ovarian granulosa cell tumors
- Monitoring the effectiveness of surgical or chemotherapy treatment
- Early detection of tumor recurrence after treatment
Book Inhibin A Ovarian Test in Saudi Arabia | Lahalak Medical Platform
Inhibin A screening is a vital tool for early detection and monitoring of ovarian granulosa cell tumors, helping evaluate treatment efficacy and ensuring prompt medical intervention in case of recurrence.
Scientific name: Inhibin A Screening for Ovarian Granulosa Cell Tumors
A laboratory blood test measuring Inhibin A levels, serving as a specific tumor marker for diagnosing adult-type granulosa cell tumors and monitoring treatment response or potential recurrence.
Service type
Laboratory test
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Blood sample collection
- Inhibin A level analysis
- Laboratory results report
Medical Service Information
Target Groups
- Women with a suspected pelvic mass
- Patients previously treated for granulosa cell tumors
- Routine follow-up cases after ovarian tumor resection
Frequently Asked Questions
- Is fasting required? No, fasting is not necessary.
- When will results be ready? Usually within 3 to 5 working days.
- Does this replace imaging? No, it is a complementary test to radiological and clinical findings.
Conditions & Notices
- Inform the doctor of all current medications
- Test is not affected by the menstrual cycle in tumor monitoring cases
Medical services you might also like
